Last reviewed · How we verify

NCT05276362

Study Watch Sleep Metric Performance Characterization Study

Completed Last updated 2 May 2024
What this trial tests

trial testing Study Watch in Sleep in 90 participants. Completed in 20 September 2023.

Timeline
4 March 2022
Primary endpoint
20 September 2023
20 September 2023

Quick facts

Lead sponsorVerily Life Sciences LLC
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date4 March 2022
Primary completion20 September 2023
Estimated completion20 September 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Verily Life Sciences LLC — full company profile →

Who can join

Adults 18 to 80, any sex, with Sleep or Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-center, single-arm, prospective performance evaluation study designed to assess performance of sleep metrics calculated from sensor data that is collected from two versions of the Verily Study Watch as compared to polysomnography.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Performance of the Verily Study Watch for measuring sleep compared to polysomnography.
    Saeb S, Nelson BW, Barman P, Verma N, et al · · 2024 · PMID 41424491 · DOI 10.3389/frsle.2024.1481878
  2. Performance of the Verily Study Watch for Measuring Sleep Compared to Polysomnography
    Saeb S, Nelson BW, Barman P, Verma N, et al · · 2024 · DOI 10.1101/2024.09.10.24313427

Verify or expand the search:

Other trials of Study Watch

Trials testing the same drug.

Other recruiting trials for Sleep

Currently open trials in the same condition.

Other Verily Life Sciences LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05276362.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing